We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Ultrasound Technology Using AI Algorithms Has Potential to Achieve 100 Times Greater Sensitivity

By MedImaging International staff writers
Posted on 25 Oct 2021
Illustration
Illustration

A novel ultrasound technology, using patented hardware, software, and artificial intelligence (AI) algorithms could deliver 100 times higher sensitivity than other ultrasound systems in the market.

DeepSight Technology (San Francisco, CA, USA) is augmenting diagnostic medical imaging with the introduction of its novel ultrasound technology that improves ultrasound image quality and more than doubles the effective range when compared to conventional technologies.

DeepSight’s solution incorporates patented hardware, software and AI technologies that vastly improve image quality and extend the depth penetration of medical diagnostic ultrasound - unleashing its full potential. DeepSight imaging solutions are expected to broaden the realm of applications where existing ultrasound technology has been limited and would otherwise require unsafe, more costly and less accessible imaging modalities such as CT or MRI. It aims to improve the speed, range and accuracy of imaging and diagnosis across a range of applications.

Whether for abdominal, breast, or obstetrical applications, there is a need for better image clarity at depths well beyond the range of today’s state-of-the-art scanners. Better sensitivity can help with the identification of masses hard to see with conventional ultrasound. The visualization of tumor structure and blood flow to differentiate between malignant and benign tumors and the ability to accurately assess treatment response can help reduce the need for other diagnostic and interventional methods. DeepSight’s vision is to provide the clarity needed for fast and accurate diagnoses and avoid the need for additional imaging.

"We are excited to be on the frontier of advancing medical imaging," said founder and CEO Nader Sadrzadeh. "Based on internal studies, our technology has the potential to achieve 100 times greater sensitivity, ultimately allowing us to deliver better patient care."

Related Links:
DeepSight Technology 

Ultrasonic Pocket Doppler
SD1
Ultrasound Needle Guidance System
SonoSite L25
High-Precision QA Tool
DEXA Phantom
X-ray Diagnostic System
FDX Visionary-A

Channels

General/Advanced Imaging

view channel
Image: The study developed a marker based on the analysis of routine CT scans of gastric cancer patients treated at UNICAMP. Higher radiodensity values for adipose tissue are linked to a worse prognosis. In contrast, higher values for muscle are linked to a more favorable outcome (Photo courtesy of FCM-UNICAMP)

CT-Derived Biomarker Predicts Outcomes in Gastric Cancer

Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.